Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial
Obesity · 2023-02 · 31 (2) · 338-349
DOI: 10.1002/oby.23618 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obesity, online erschienen am 09.01.2023. Verfasst von Katherine A Collins und 8 weiteren Autor:innen. Beteiligte Einrichtung: Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Weight Reduction Programs, Insulin Resistance, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Objective
This study aimed to determine whether novel biomarkers of cardiometabolic health improve in response to a 12‐month behavioral weight‐loss intervention and to compare benefits of diet alone with diet plus physical activity for these biomarkers.
Methods
Participants ( N = 374) were randomized to either diet alone (DIET), diet plus 150 min/wk of prescribed moderate‐intensity physical activity (DIET + PA150), or diet plus 250 min/wk of prescribed moderate‐intensity physical activity (DIET + PA250). Biomarker concentrations were determined using nuclear magnetic resonance spectroscopy. Mixed models assessed for a time effect, group effect, or group by time interaction.
Results
All groups significantly improved body weight (time: p < 0.0001), Lipoprotein Insulin Resistance Index score (time: p < 0.0001), Diabetes Risk Index score (time: p < 0.0001), branched‐chain amino acid concentration (time: p < 0.0001), and GlycA concentration (time: p < 0.0001), with no group effect or group by time interactions.
Conclusions
All intervention groups prompted a notable beneficial change among biomarkers of insulin resistance and cardiometabolic health. However, the addition of at least moderate‐intensity physical activity to a diet‐only intervention did not provide any additional benefit. These findings highlight that an average weight loss of approximately 10% profoundly impacts biomarkers of insulin resistance and cardiometabolic disease in adults with overweight or obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Duke Molecular Physiology Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
- Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
- Wondr Health, Dallas, Texas, USA.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
- Cooperative Studies Program Epidemiology Center-Durham, Durham VA Health Care System, Durham, North Carolina, USA.
- Center on Aging and Mobility, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Katherine A Collins
Förderung
- NCATS NIH HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Human Genome Research Institute
Zitieren
APA
Collins, K. A., Kraus, W. E., Rogers, R. J., Hauser, E. R., Lang, W., Jiang, R., Schelbert, E. B., Huffman, K. M., & Jakicic, J. M. (2023). Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial. Obesity, 31(2), 338-349. https://doi.org/10.1002/oby.23618
Vancouver
Collins KA, Kraus WE, Rogers RJ, Hauser ER, Lang W, Jiang R, et al. Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial. Obesity. 2023;31(2):338-349. doi:10.1002/oby.23618
BibTeX
@article{Collins2023,
author = {Collins, Katherine A and Kraus, William E and Rogers, Renee J and Hauser, Elizabeth R and Lang, Wei and Jiang, Rong and Schelbert, Erik B and Huffman, Kim M and Jakicic, John M},
title = {Effect of behavioral weight‐loss program on biomarkers of cardiometabolic disease risk: Heart Health Study randomized trial},
journal = {Obesity},
year = {2023},
volume = {31},
number = {2},
pages = {338--349},
doi = {10.1002/oby.23618}
}
EUVIMED